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Background: To determine how the mechanical property and micro structure affect
tissue regeneration and angiogenesis, three types of scaffolds were studied. Acellular
dermal matrices (ADM), produced from human skin by removing the epidermis and
cells, has been widely used in wound healing because of its high mechanical
strength. Collagen scaffolds (CS) incorporated with poly(glycolide-co-L-lactide) (PLGA)
mesh forms a well-supported hybrid dermal equivalent poly(glycolide-co-L-lactide)
mesh/collagen scaffolds (PMCS). We designed this scaffold to enhance the CS mechanical
property. These three different dermal substitutes—ADM, CS and PMCSs are different in
the tensile properties and microstructure.
Methods: Several basic physical characteristics of dermal substitutes were investigated
in vitro. To characterize the angiogenesis and tissue regeneration, the materials were
embedded subcutaneously in Sprague–Dawley (SD) rats. At weeks 1, 2, 4 and 8
post-surgery, the tissue specimens were harvested for histology, immunohistochemistry
and real-time quantitative PCR (RT-qPCR).
Results: In vitro studies demonstrated ADM had a higher Young’s modulus (6.94 MPa)
rather than CS (0.19 MPa) and PMCS (3.33 MPa) groups in the wet state. Compared
with ADMs and CSs, PMCSs with three-dimensional porous structures resembling skin
and moderate mechanical properties can promote tissue ingrowth more quickly after
implantation. In addition, the vascularization of the PMCS group is more obvious than
that of the other two groups. The incorporation of a PLGA knitted mesh in CSs can
improve the mechanical properties with little influence on the three-dimensional
porous microstructure. After implantation, PMCSs can resist the contraction and
promote cell infiltration, neotissue formation and blood vessel ingrowth, especially
from the mesh side. Although ADM has high mechanical strength, its vascularization
is poor because the pore size is too small. In conclusion, the mechanical properties of
scaffolds are important for maintaining the three-dimensional microarchitecture of
constructs used to induce tissue regeneration and vascularization.
Conclusion: The results illustrated that tissue regeneration requires the proper pore
size and an appropriate mechanical property like PMCS which could satisfy these
conditions to sustain growth.
Keywords: Knitted mesh, Microstructure, Angiogenesis, Tissue regeneration,
Mechanical properties© 2013 You et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
You et al. BioMedical Engineering OnLine 2013, 12:125 Page 2 of 17
http://www.biomedical-engineering-online.com/content/12/1/125Background
Full-thickness skin defects resulting from injury, burns and nonhealing ulcers represent
a significant clinical problem that is far from being solved. At present, the main treatments
for skin defects are transplantations such as autografts, allografts and xenografts to ensure
wound closure as soon as possible [1,2]. Tissue engineering of whole skin represents an
equally attractive and ambitious novel approach [3]. Many skin tissue engineering methods
have been developed for the treatment of full-thickness skin defects [4,5]. Although tissue
engineering has a significant potential to provide alternative approaches for skin
regeneration, several problems have hampered progress in translating technological
advances to clinical reality [6,7]. The skin split-thickness autograft has been widely
used but frequently leads to scarring in full-thickness wounds because of the lack
of dermis. Therefore, dermal reconstruction or regeneration is the critical issue to
reduce scar formation and improve the quality of wound healing; this has encouraged the
initiation and development of dermal substitutes [8-12]. Several products have been
manufactured and used clinically. However, none of them were able to perfectly regenerate
skin for various reasons, including unsuitable physical or mechanical properties
and inappropriate microstructures that hinder the cellular infiltration, proliferation
and differentiation [13]. The ideal substitutes should have suitable properties that
effectively induce rapid angiogenesis, a significant challenge in the field of tissue
engineering and regenerative medicine, which is one of the crucial premises to promote
regeneration and decrease the risk of infection [14,15].
Dermal regeneration scaffolds regulate the tissue and cells’ regeneration as an external
force during the process of extension and growth of cells in the material. These materials
are capable of not only inducing tissue regeneration and vascularization but can also
inhibit the hyperplasia. Studies have proven that collagen-based scaffolds possess many
interesting properties but also that they possess weak mechanical properties for skin tissue
engineering applications [16-18]. Many approaches, such as physical/chemical crosslinking,
have been developed to improve the biomechanical function of scaffolds, and the results
seem obvious [19-21]. Some researchers have reported that a knitted mesh from artificial
polymers is a good way to provide collagen-based scaffolds with excellent mechanical
properties, and this type of hybrid scaffold has been successfully applied to repair
cartilage, ligaments, tendons, blood vessels, etc. [22-26]. In our previous study, we
found that mesh-reinforced collagen-chitosan scaffolds can resist contraction and
promote cell infiltration, neotissue formation, and blood vessel ingrowth more effectively
than collagen-chitosan scaffolds [27]. Based on these studies, we developed poly
(L-lactide-co-glycolide) (PLGA) yarns knitted into mesh-reinforced collagen scaffolds to
enhance the collagen scaffolds’ mechanical properties. For skin tissue engineering, several
types of meshes knitted by PLGA or poly(lactic acid-co-caprolactone) (PLACL)
were integrated with collagen to fabricate dermal substitutes, and the primary results
illustrated that using the knitted mesh as a “skeleton” improved the mechanical strength
of the hybrid scaffolds and inhibited wound contraction [27-29].
ADM matrix, which is rich in predominantly type-I collagen, is increasingly used
in reconstructive surgery applications [30]. Therefore, the in vivo influence of this
type of hybrid scaffold on inductive regeneration and angiogenesis has been widely
investigated in skin tissue engineering. Compared with artificial polymers, ADM
materials (ADMs) as naturally derived biomaterials have excellent mechanical
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cell infiltration [31].
Collagen scaffold, PLGA-Collagen scaffold and ADM are three types of dermal
substitutes composed of collagen with different mechanical properties and microstructure
characteristics. What type of role does the biomechanics and microstructure play in
wound healing? In this study, we chose these three types of scaffolds mentioned above to
represent the low (CS), intermediate (PMCS), and high (ADM) mechanical property
scaffolds to determine which one is most suitable for dermal regeneration. PMCS was
prepared by incorporating the PLGA knitted mesh (PLGAm) into collagen scaffold (CS)
as a hybrid scaffold to study the function of the mechanical properties and microstructure
in tissue regeneration. Young’s modulus as a physical quantity of the ability to resist
deformation of solid material was measured to illustrate the mechanical properties.
The hypothesis that tissue regeneration and angiogenesis is possibly dependent on
porous microstructure and suitable mechanical properties of scaffolds was tested
by investigating the angiogenic and regenerative potentials of the three scaffolds
implanted subcutaneously in a rat model. The study protocol was approved by Institutional
Review Board at the Zhejiang University.Materials and methods
Materials
PLGA (LA/GA = 1:9, molecular weight: 80–110 kD) yarns were provided by Foryou
Medical Devices Co., LTD (China), and Genipin was purchased from Linchuan Zhixin
biological technology Co., LTD (China). Type I collagen was extracted and purified
from fresh bovine tendons by swelling, deleting telopeptides with pepsin, and sufficient
dialysis as described previously [14,27]. ADM, purchased from Beijing Jayyalife
biological Technology Co., Ltd. is native dermal matrix from cadaver skin by removing the
epidermis and other cells contain a complete basement membrane. It is milky white and
flexible which could be used as “permanent” dermal substitute materials. Analytical-graded
reagents and deionized water were utilized in the experiments.Manufacturing of PLGA mesh
The PLGA yarns (25 filaments/yarn; diameter of filament, 15 μm) were knitted into a
network with a braiding machine (HKS3-M, China). The knitted fabrics were rinsed in
acetone for 15 min, washed in deionized water with ultrasonic waves for 15 min × 3
times, desiccated in the vacuum dryer at 45°C for 24 h, and then thermally formed at
105°C for 24 h. Finally, they were stored under vacuum at 4°C prior to application.One-step crosslinking to prepare CS and PMCS
The PMCS was prepared by integrating knitted mesh into porous CS. First, bovine type
Ι collagen was dissolved in 0.5 M acetic acid and a 0.5% genipin mixed solution to form
a 0.05% (w/v) solution [32,33]. In our previous work, we compared different crosslink
concentration of genipin, the suitable concentration of genipin was determined by
analysis of pore size, mechanical strength and other activities. The PLGA mesh
was cut into designated sizes (4.0 cm × 4.0 cm) and then extended on the flat plate
of the homemade model (4.0 cm × 4.0 cm × 0.2 cm). A 3.2 ml collagen/chitosan
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was standing at −4°C for 24 h, frozen at −25°C for 3 h, and then lyophilized for
16 h to produce the hybrid scaffold. The porous PMCS was prepared and treated
as previously described [27,34].
Before being implanted in animal experiments, the scaffolds were sterilized with 70%
ethanol for 30 min and then washed completely with sterilized phosphate buffer solution
(PBS) 5 times, each for 15 min.
Physical evaluation
After being sectioned with a razor blade and coated with platinum, the morphologies
of ADM, CS and PMCS were observed using SEM (Philips XL30, Eindhoven, The
Netherlands). The accelerating voltage was set at 1.0 kV. To determine the mean pore
size of the scaffolds, images of cross-sectioned surfaces from CS and PMCS were
analyzed as described previously [27]. Three SEM images of each scaffold were
taken randomly. In each, ten apparent pores were selected and measured with a
ruler. The long and minor axes of pores in a perpendicular direction were measured, and
the average was taken as the mean pore size.
Young’s modulus of ADM, CS and PMCS in dry and wet conditions was measured
with a universal testing machine (Instron, model 5543, High Wycombe, UK). Before
the tests, the samples were trimmed into 4.0 cm × 1.0 cm pieces. Six samples in
one group were divided into two subgroups. One subgroup was prepared for the
dry measurement, and the other was first immersed in PBS for 1 h and then measured.
Each sample was stretched at a rate of 1 mm/min at 20 ± 2°C. Finally, the ultimate Young’s
modulus was calculated according to formula 1 [35].
EM ¼ F=A0ð Þ= ΔL=L0ð Þ
Formula 1. EM is the elasticity modulus; F is the mechanical force applied to thesample; A0 is the original cross-sectioned area; ΔL is the change amount by which the
length of sample; and L0 is the original length of the sample.
In vivo implantation
All the animal experimental procedures were carried out under the Zhejiang University
animal care and use committee. Adult Sprague–Dawley (SD) rats, male, aged 2 months
and weighing 200 ± 8 g, were purchased from the Experimental Animal Centre of
Zhejiang University. After the hair on the backs of the rats was trimmed and removed,
the rats were anesthetized by an intraperitoneal injection of 3% pentobarbital sodium
solution (Sigma) at a dosage of 1.0 mL/kg. After local disinfection with 2.5% povidone
iodine solution, the sterilized ADM, PMCS and CS scaffolds (diameter 2.0 cm) were
embedded into the subcutaneous tissue pockets of rats. At intervals of 1, 2, 4, and 8 weeks
after the operation, the rats were killed with a lethal dose of pentobarbital sodium solution,
and then the rat skin was incised and turned open along the midline on the back to expose
the embedded objects. Pictures of the implants were taken, and the tissue specimens were
obtained and kept in 10% neutral formalin aqueous solution and liquid nitrogen for
histopathological observation and molecular biological detection, respectively. At
each time point, six parallel scaffolds were set for each group.
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The tissue samples were prepared and embedded in paraffin. The paraffin blocks were
all sectioned at a thickness of 5 μm and stained by hematoxylin & eosin (HE) staining
and Masson trichrome staining. The stained sections were visualized under an optical
microscope.Immunohistochemistry
The infiltration of blood vessels into the implants was evaluated morphologically by
examining the critical factors relative to the process of angiogenesis such as CD31 and
α-SMA by immunohistochemistry.
For the immunohistochemical staining, the pretreatment of paraffin-embedded tissue
samples was conducted as described before [36]. After heat repairing of antigens in
0.01 M citrate buffer aqueous solution at 95°C for 6 ~ 8 min, the nonspecific antigens
were blocked with 5% goat serum at 37°C for 30 min. Then, the sections were exposed
to rabbit anti-CD31 primary antibody (1:100, Abcam, Cambridge, UK) at 4°C overnight.
After 3 washes with PBS, the sections were incubated with goat anti-rabbit secondary
antibody at 37°C for 30 min, developed and counterstained with 3, 3’-diaminobenzidine
tetrahydrochloride (DAB) solution and hematoxylin, respectively. The positive areas
stained with brown color were observed under an optical microscope.RNA isolation and real-time semiquantitative PCR analysis
The scaffolds embedded subcutaneously in the rats for 1, 2, 4, and 8 weeks were
harvested to isolate RNA for the RT-sPCR analysis. Each sample was dissolved in 1 mL
of Trizol reagent (Invitrogen, CA, USA), and RNA was isolated. The content and purity
of RNA were measured with an ultraviolet spectrophotometer after dissolving RNA in
DEPC-H2O solution. RNA conversion to cDNA was carried out with an M-MLV
Reverse Transcriptase cDNA synthesis kit (Promega, WI, USA). RT-sPCR was amplified
for CD31, VEGF, PDGF-BB and α-SMA and the calibrator reference gene (glyceralde-
hyde-3-phosphate dehydrogenase, GAPDH). The reaction was performed with iQTM5
Multiple Real-time Fluorescent Quantitation PCR Determinator (Bio-Rad, USA) for
40 cycles. The expression level of each target gene was normalized to GAPDH and
calculated using Bio-Rad icycler software (version 2.0). The fluorescent primers
were devised with Primer Express 2.0 (ABI, USA) and Beacon Designer software
(Bio-Rad, USA) and were obtained from Shanghai Bioengineering Co., Ltd. (China).
The detailed sequences are shown in Table 1.Statistical analysis
All quantitative data were analyzed with SPSS 16.0 (USA) and presented as the
mean ± standard deviation. Significant differences among specimens were evaluated
by a t-test. A value of p < 0.05 was regarded as significant.Results
Physical observation
The microstructures of ADM, CS and PMCS are shown in Figure 1. The PLGAm had a
net-like structure with a loop size of 350 ± 12 μm (Figure 1A). CS had a mean pore size
Table 1 Real-time primer sequences and condition
Gene Sourcea Primer sequencesb Size(bp) Annealing
CD31 NM031591.1 F 5-GGAGGTGACAGAAGGTGGGATTG-3 66 60°C
R 5-GCTTGGCAGCGAAACACTAACAGG-3
PDGFBB NM031524 F 5-CCCACACGTCAAACTACAGCTCCAA-3 112 60°C
R 5-GCCCAGTTCGTTTCAGTGCCACAT-3
α-SMA NM031004 F 5-CCAGGGAGTGATGGTTGGAATG-3 98 60°C
R 5-GCCGTGTTCTATCGGATACTTCAG-3
VEGF NM031836 F 5-GGCTTTACTGCTGTACCTCCACCAT-3 161 60°C
R 5-CGGGGTACTCCTGGAAGATGTC-3
GAPDH NM017008 F 5-GGTGGACCTCATGGCCTACAT-3 88 60°C
R 5-GCCTCTCTCTTGCTCTCAGTATCCT-3
aIndicates GeneBank accession numbers where applicable. bIndicates the sequences of forward (F) and reverse (R) primers.
Ration, respectively (n = 3).
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pores were not obvious in ADM (Figure 1B) [37]. In the hybrid scaffold, the mesh was
located near the lower side and interconnected contiguously with collagen/chitosan
structures (Figure 1C). Meanwhile, the collagen/chitosan sponge in the PMCS
remained porous and interconnected and occupied the openings of the PLGA mesh
(Figure 1C, F). The collagen/chitosan sponge had an average pore size of 112 ± 5 μm
and a porosity of 91%, similar to those of CS.
Figure 2 illustrates the Young’s modulus of ADM, CS and PMCS in wet and dry
states. In wet state, the Young’ modulus of CS was much lower (0.19 MPa) than the
others. Meanwhile, PMCS retained suitable Young’s modulus (3.33 MPa) similar to that
of human native dermis (1.03-3.10 MPa) [38]. While ADM was the highest (6.94 MPa).Gross observation
For all 3 groups, no evident inflammatory reaction, e.g., infection, fistula and fibrous
capsule, was observed in the implantation and adjacent sites at different time points. At
week 1, the implants had integrated into the surrounding tissues, and several blood vessels
could be observed around the implants in PMCS and CS. This process was not obvious in
ADM. ADM and PMCS maintained a similar shape and area with the first state.
Meanwhile, the residual area of CS reached nearly 70% of the previous area.
Two weeks after implantation, more blood vessels grew into the implants and the
color of the implants turned to light red in the PMCS and CS groups. Several blood
vessels could be observed around the ADM group, but the surrounding tissue was not
close. In the PMCS group, the mesh loops became indistinguishable, which possibly
resulted from the neotissue ingrowth induced by the scaffolds. The residual areas
of ADM and PMCS changed little, while CS underwent obvious contraction.
From weeks 2 to 4, more abundant blood vessels could be visualized in and around
the PMCS and CS groups compared with ADM, and the outlines became indistinct.
The appearances of scaffolds were similar to the normal tissue. The residual areas of
PMCS and ADM were significantly larger than those of CS. With the increase of
implantation time, most of the scaffold structures gradually became invisible. At




Figure 1 SEM images PLGA mesh (A), CS (B, E), PMCS (C, F) and ADM (D).
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The implants were harvested at different times for histological analysis to evaluate the
tissue response to the three different types of scaffolds, and the results of HE staining
are shown in Figure 3. At week 1, the implants were easily distinguished from the host
tissues in all the groups. Inflammatory cells such as granulocytes and macrophages
were observed at this stage. In the PMCS group, fibroblasts grew into the implants
from the mesh side rapidly, and abundant ECM deposition was observed in the center
of PMCS (Figures 3A, D, G). In the ADM and CS groups, the infiltration of fibroblasts
was mainly distributed around the scaffold with a thin ECM secretion (Figures 3A, B).
Additionally, newly formed blood vessels in the PMCS were observed, while most areas
in the center of the CS and ADM did not exhibit cell or capillary infiltration
(Figures 3A, B, C). Two weeks after implantation, the implants were closely integrated
with the adjacent tissues, except in the ADM group. The number of granulocytes
decreased, and the number of macrophages increased in all three groups. The









Figure 2 Young’s modulus of PMCS, CS and ADM. (A) Young’s modulus of PMCS, CS and ADM,
respectively (n = 6), p < 0.001. (B) The representative stress–strain curves for the three scaffolds in both dry
and wet state: (a, b) ADM, (c, d) CS, (e, f) PMCS. The X-axis represented tensile strain (mm/mm) and the
Y-axis represented tensile stress (MPa). The calculation was completed by the computer. Generally, the slope
of the curve is the Young’s modulus.
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Meanwhile, blank areas without cell ingrowth remained in the CS and ADM
groups (Figures 3H, I). At week 4, newly formed tissue became more abundant,
and the number of macrophages showed down-regulation in all the groups. The
degradation of the three types of scaffolds was more obvious than before, and their
outlines were difficult to discriminate from the host tissues. Especially in the




Figure 3 HE staining of PMCS, CS and ADM. HE staining of sections of the PMCS (A, D, G), CS (B, E, H)
and AD (C, F, I) implanted for 1, 2, 3 weeks after operation. The Bar indicates 100 μm. The red arrows
indicate the scaffolds.
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degraded completely, while some residual components remained in the ADM
group (Figures 3G-I).Masson trichrome staining
To investigate collagen deposition, Masson trichrome staining was performed, and the
results are illustrated in Figure 4. In all the groups, the quantity of collagen deposition
increased with the prolongation of the implantation time. At week 1, many blue
collagen fibrils were observed near to the mesh side in the PMCS group, while a
few fibrils were distributed around the ADM and CS groups. At week 2, compared
with the collagen deposition throughout the PMCS, there were some fibrils positioned in
the scaffolds near to the surfaces in the other groups. At week 4, more collagen fibrils
appeared in the PMCS group, and the fibrils were more homogenous and ordered
than those of other groups. From weeks 4 to 8, more abundant and ordered collagen
deposition was observed in the PMCS group, while the CS and ADM groups revealed a
heterogeneous collagen distribution.Immunohistochemistry
To characterize the newly formed blood vessels in the implants, α-SMA, CD31
(a marker of endothelial cells around the blood vessels) immunohistochemical staining
was performed, and the results are illustrated in Figure 5 and Figure 6. This indicates
that the number of blood vessels increased to some extent for all the groups with




Figure 4 Masson staining of sections of the PMCS, CS and AD. Masson staining of sections of the
PMCS (A, D, G), CS (B, E, H) and AD (C, F, I) implanted for 1, 2, 3 weeks after operation. The Bar indicates
100 μm. Light blue indicates newly-formed collagen, and red indicates cytoplasma.
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distributed around the implants, particularly in the PMCS group, and the density
was significantly higher than that in CS and ADM. At week 2, the blood vessel
densities of PMCS increased, respectively, and the values are also significantly
higher than those of CS and ADM. At 4 and 8 weeks after implantation, the
PMCS and CS groups displayed strong positive staining, while some blank fields
could be found in the ADM group. The number of blood vessels in the PMCS
group continued to increase and was higher than that of other groups with a significant
difference at the different time points.RT-qPCR analysis
Angiogenesis at the gene level was further characterized by quantifying several critical
factors, such as CD31, α-SMA, VEGF and PDGF-BB, using RT-qPCR. Generally, the
trends of gene expression in the 3 groups fluctuate regardless of the types of genes,
whereas the PMCS group always retained a higher gene expression level at different
time points. When compared within the different implantation periods, the CD31,
α-SMA, VEGF and PDGF-BB mRNA expressions of the PMCS group were always
significantly higher than those of other groups (Figure 7).Discussion
The biology mechanical property participates in the whole process of wound healing.
Activated and proliferating fibroblasts derived from local resting cells induced by
DA B C
E F
Figure 5 α-sma immunohistochenmical staining. α-sma immunohistochenmical staining of sections of
the PMCS (A, D), CS (B, E) and AD (C, F) for 2 weeks after operation. D, E, F are the enlargement of the
bos area in A, B, C. The Bar indicates 100 μm. Arrows indicate blood vessels.
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apparatus appear in the wound 2–3 d after injury. In response to tensile stress,
proto-myofibroblasts differentiate into highly contractile myofibroblasts that express
α-SMA [39]. Biomechanical stress generated by fibroblasts that migrate into the fibrin
matrix from tissues surrounding the wound or wound contraction could direct translocation
of the vasculature and regulate the other cells’ biological behavior [40,41]. Interconnected by
gap junctions, myofibroblasts secrete extracellular matrix components and at the same time
contract the wound by transmitting tension across intracellular actin stress fibers connected
to the extra-cellular matrix [40]. Engineered scaffolds just replace the role of extra-cellular
matrix which should possess such a mechanical and structural pattern for angiogenesis.
Tissue engineering is based on the idea of biomimetic materials science to emulate
the target tissue or organ closely in terms of material composition, structure, material
surface properties and mechanical properties and to devise a substitute [42,43]. NaturalBA C
ED F
Figure 6 CD31 immunohistochenmical staining. CD31 immunohistochenmical staining of sections of
the PMCS (A, D), CS (B, E) and AD (C, F) for 2 weeks after operation. The Bar indicates 100 μm. Arrows
indicate blood vessels.
Figure 7 Real-time quantitative analysis of CD31, α-SMA, VEGF and PDGF-BB. Real-time quantitative
analysis of CD31 (A), α-SMA (B), VEGF (C) and PDGF-BB (D) mRNA expression of the implants at 1, 2, 4
weeks after operation, respectively (n = 3). ∗ indicates statistically significant difference, p < 0.05.
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from the animal body, and some other organisms extract. Cell aggregation and tissue
formation induced by scaffolds must be supplied with enough nutrients by the vascular
system, indicating that the velocity of vascular infiltration should match that of tissue
formation. The rapid construction of microcirculation in the equivalents can facilitate
cell adhesion, proliferation and functionalization by transmitting oxygen and nutrients
and taking metabolic waste away. Therefore modification of the scaffolds’ physicochemical
properties is important to enhance the function. The biological environment provided by
biomimetic scaffolds is a network of structural and functional components [44,45].
Many researchers have studied the relationship between mechanical strength and
dermal regeneration. Techniques such as optimizing the pore size to enhance its
mechanical property indicated that three-dimensional porous structures commonly
characterized by porosity, pore size and interconnectivity can support cell migration and
guide vascular infiltration [27,34,46]. Some in vitro studies focusing on the optimal mean
pore size of collagen-based scaffolds indicated that large pores (≥250 μm) favor cell
attachment, proliferation and migration [47-51]. In addition to crosslinking which
could improve the microstructure and mechanical properties are the most basic
methods of biomimetic scaffolds. It is obvious that the biomechanical strength
plays an important role in wound healing, but what type of mechanical property
and microstructure a perfect dermal scaffolds should have is still unsolved. In this
research we compared three different dermal scaffolds to explore the reasonable
mechanical property and microstructure.
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application of collagen scaffolds. Collagen scaffolding has been proven to possess
excellent biocompatibility and biodegradability and is a quite suitable material for
skin tissue engineering [52,53]. However, without sufficient mechanical properties,
it is always compressed or crumpled and cannot maintain its porous structure. It
was demonstrated by the test of Young’s modulus (Figure 2). The knitted mesh in
this experiment is composed of PLGA (LA/GA = 1:9) yarns, which are polyesters
and have been approved by the FDA for clinical use. In a previous study, the PLGA mesh
was incorporated into collagen scaffolds to assemble PMCSs and support structures for
3D porous structures (Figure 1B, E) for cell aggregation and vascular infiltration. The
introduction of PLGA mesh into CS had little influence on the microstructure of the
collagen sponge (Figure 1D, E) and improved the mechanical properties of the hybrid
scaffold to a level similar to that of normal dermis (1.03-3.10 MPa) (Figure 2) [38].
ADM is prepared from human dermal tissue by removing the cells and epidermis. ADM
has been widely used for wound regeneration because of its excellent biocompatibility
and mechanical properties that mimic human acellular dermis through its ability to
naturally interface with host tissues with minimal tissue response [54,55]. However,
its high mechanical property is based on a small and collapsed aperture which
could be observed on Figure 1C.
The angiogenesis of all three groups was systematically investigated. Gross observation
provides direct evidence of angiogenesis at the early implantation stage. As the implantation
time and vessel density increased, advanced testing methods were needed to count the
number of the newly formed blood vessels. In this study, newly formed blood vessels were
specially marked by immunochemical staining for CD31 (Figure 6), a type I integral
membrane glycoprotein expressed by endothelial cells early in vascular formation
[56]. With the maturation of the blood vessels, another cell layer composed of
smooth muscle cells occurred around the endothelial layer, and this layer expresses
α-SMA (Figure 5). Compared with CS, the knitted mesh mechanically supports the
3D porous microstructure of the collagen sponge, facilitating the transmission of
oxygen and nutrients and the infiltration of cells and blood vessels. In addition, the
proper mechanical strength can also change regularly according to the requirement of
neotissue and new blood vessel growth. Although the mechanical properties of ADM are
better than those of PMCS, the angiogenesis results are not good. The histology result
showed that the infiltration of fibroblasts and vessels was mainly distributed around the
scaffolds (Figure 3). The microstructures of ADM showed the collapsed hole and tousle
structure with burliness fiberboard tier upon tier. The high mechanical strength of ADM
made it relatively difficult to deform, which blocked the tissue regeneration. Further
evidence of angiogenesis was provided by RT-qPCR, which was used to investigate
the expressions of CD31, α-SMA, VEGF and PDGF-BB at the gene and protein
levels (Figure 7). Among these key factor related to vascular development, VEGF
can promote vascular development and maturation with a tiny dose; PDGF-BB,
often released by endothelia cells at the sprouting tip of forming capillaries, is not involved
in the initial vessel formation but in the neovessel stability and functionalization by inducing
anastomoses and mediating pericyte recruitment [57,58]. The results of RT-qPCR indicate
that the PMCS group exhibited the highest mRNA expression of VEGF and PDGF-BB,
gradually increasing from weeks 1 to 4 and decreasing in week 8. The results of molecular
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much higher level of angiogenesis than the other two groups. All these results confirm that
moderate mechanical properties and proper physical structure have a basic and critical
influence on the rapid angiogenesis of dermal equivalents. Only the proper mechanical
strength and aperture could promote the tissue and cell ingrowth. Both CS and ADM
have homogeneous holes and compositions, but the PMCS has a variable structure with a
mesh positioned at one end that produces a 3D mode with a graded aperture in which the
holes from the mesh side to the collagen side are gradually enlarged. This is in line with
the general laws of the material-induced regeneration of tissue and cells.
Tissue engineering has proven to be one of the most promising alternative therapies
for wound healing and tissue regeneration [59]. In this study, scaffold degradation
and in situ tissue regeneration can be observed simultaneously. In the in vivo
microenvironment, the degradation of scaffolds is a complex process involving
hydrolyzation and biodegradation. CS required no less than 4 weeks to be assimilated by
the host tissue, in contrast to ADM and PMCS [14,53]. In the PMCS group, the outlines
of PLGA fibers remained relatively intact at weeks 1 and 2, displayed obvious degradation
phenomena with fiber fracturing and crushing, and almost degraded completely with a
little residue surrounded by macrophages and neotissue at week 8, which resulted in a
stronger resistance to contraction in the early stage than that of CS (Figure 3A, D, G).
Almost 8 weeks later, the outline of the ADM was still visible with HE (Figure 3C, F, I)
and Masson’s staining (Figure 4C, F, I). Fibroblast infiltration and collagen secretion in the
3 types of implants were visualized well by HE and Masson’s staining. From week 1 to 2,
the PMCS group promoted the fastest cell infiltration and ECM formation, especially in
the portion near the mesh side, which resulted from the rapid angiogenesis described
above. Abundant and ordered collagen deposition was closely related to the up-regulation
of fibroblast function in the local microenvironment. It has been reported that cell activity
is mainly regulated by the specific surface area (SSA) in the scaffold, from which the space
distribution is determined by the geometrical structure of the constructs [48]. In the
in vivo complex biomechanical environment, the existing knitted mesh in the PMCS can
maintain a geometrical microstructure and SSA distribution suitable for fibroblast activity
to reach a higher level of tissue regeneration induced by the hybrid scaffold. Scaffolds
should possess suitable mechanical properties to maintain 3D porous structures for tissue
ingrowth and provide temporary mechanical support until the regenerated tissue
can support mechanical loads.Conclusions
The rational selection and collocation of biomaterials help design biomimetic DRT.
Incorporation of the PLGA knitted mesh into a collagen/chitosan porous scaffold with
lyophilization formed a reinforced hybrid scaffold with excellent mechanical property
and a suitable microstructure. When embedded into the dorsal subcutaneous pockets,
PMCS can resist the contraction, induce cell infiltration and neo-tissue formation, and
promote blood vessel ingrowth compared with CS. ADM has a high mechanical
property that is large enough to resist contraction, but without a porous structure
and elastic strain capacity, the angiogenesis that induces tissue regeneration is delayed.
Hence, the ideal scaffolds not only require the proper mechanical strength to maintain
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of neo-tissue. This indicates that suitable mechanical functioning could be one of
the most crucial characteristics for maintaining the shape and microstructure of
the constructs to facilitate cell ingrowth and functionalization. In summary, the
mechanical properties and microstructure, which play an important role in accelerating
angiogenesis and inducing in situ tissue regeneration, are the most basic characteristics of
engineered scaffolds.
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